Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor.
Argiriadi MA, Goedken ER, Banach D, Borhani DW, Burchat A, Dixon RW, Marcotte D, Overmeyer G, Pivorunas V, Sadhukhan R, Sousa S, Moore NS, Tomlinson M, Voss J, Wang L, Wishart N, Woller K, Talanian RV.
Argiriadi MA, et al. Among authors: borhani dw.
BMC Struct Biol. 2012 Sep 20;12:22. doi: 10.1186/1472-6807-12-22.
BMC Struct Biol. 2012.
PMID: 22995073
Free PMC article.